Needham Downgrades KnowBe4 to Hold

Needham analyst Alex Henderson downgrades KnowBe4 (NASDAQ:KNBE) from Buy to Hold.

Needham analyst Alex Henderson downgrades KnowBe4 (NASDAQ:KNBE) from Buy to Hold.

Total
0
Shares
Related Posts
Read More

Aileron Therapeutics Announces Oral Presentation Of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles And Their Stem Cells From Chemotherapy-Induced Damage At The European Society For Dermatological Research Annual Meeting 2022

New ex vivo data demonstrates protection against cyclophosphamide-induced damage to hair follicles and their stem cells   Encore presentation of data presented at Society for Investigative Dermatology in May

ALRN